SPECIFIC INHIBITION OF LYMPHOID COMPLEMENT RECEPTORS BY ANTI-H-2 SERA: EVIDENCE FOR A NEW H-2 LINKED POLYMORPHISM

Certain anti-H-2 sera contain an antibody-like activity which specifically inhibits EAC rosette formation by lymphoid (and not myeloid) cells of certain mouse strains. Studies in congenic recombinant mouse strains strongly indicate that at least part of the control of susceptibility to inhibition by these antisera is mediated by H-2 linked genes, mapping in the I-C subregion or the S region. The strain distribution of the trait CRIS indicates that certain H-2 identical mice behave differently from one another, pointing toward a component of non-H-2 modulation of the H-2 linked gene (or to a previously unsuspected H-2 difference). Positive sera were usually raised across differences in the D end of the H-2 complex. The complex implications of this system must be considered in the light of known S region involvement in complement metabolism.Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/73055/1/j.1744-313X.1975.tb00549.x.pd

Academic freedom: in justification of a universal ideal

This paper examines the justification for, and benefits of, academic freedom to academics, students, universities and the world at large. The paper surveys the development of the concept of academic freedom within Europe, more especially the impact of the reforms at the University of Berlin instigated by Wilhelm von Humboldt. Following from this, the paper examines the reasons why the various facets of academic freedom are important and why the principle should continue to be supported

Leprosy post-exposure prophylaxis with single-dose rifampicin

_Objective:_ Leprosy post-exposure prophylaxis with single-dose rifampicin (SDRPEP) has proven effective and feasible, and is recommended by WHO since 2018. This SDR-PEP toolkit was developed through the experience of the leprosy postexposure prophylaxis (LPEP) programme. It has been designed to facilitate and standardise the implementation of contact tracing and SDR-PEP administration in regions and countries that start the intervention. _Results:_ Four tools were developed, incorporating the current evidence for SDRPEP and the methods and learnings from the LPEP project in eight countries. (1) th

Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry.

BACKGROUND: The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF) is an ongoing prospective noninterventional registry, which is providing important information on the baseline characteristics, treatment patterns, and 1-year outcomes in patients with newly diagnosed non-valvular atrial fibrillation (NVAF). This report describes data from Indian patients recruited in this registry. METHODS AND RESULTS: A total of 52,014 patients with newly diagnosed AF were enrolled globally; of these, 1388 patients were recruited from 26 sites within India (2012-2016). In India, the mean age was 65.8 years at diagnosis of NVAF. Hypertension was the most prevalent risk factor for AF, present in 68.5% of patients from India and in 76.3% of patients globally (P < 0.001). Diabetes and coronary artery disease (CAD) were prevalent in 36.2% and 28.1% of patients as compared with global prevalence of 22.2% and 21.6%, respectively (P < 0.001 for both). Antiplatelet therapy was the most common antithrombotic treatment in India. With increasing stroke risk, however, patients were more likely to receive oral anticoagulant therapy [mainly vitamin K antagonist (VKA)], but average international normalized ratio (INR) was lower among Indian patients [median INR value 1.6 (interquartile range {IQR}: 1.3-2.3) versus 2.3 (IQR 1.8-2.8) (P < 0.001)]. Compared with other countries, patients from India had markedly higher rates of all-cause mortality [7.68 per 100 person-years (95% confidence interval 6.32-9.35) vs 4.34 (4.16-4.53), P < 0.0001], while rates of stroke/systemic embolism and major bleeding were lower after 1 year of follow-up. CONCLUSION: Compared to previously published registries from India, the GARFIELD-AF registry describes clinical profiles and outcomes in Indian patients with AF of a different etiology. The registry data show that compared to the rest of the world, Indian AF patients are younger in age and have more diabetes and CAD. Patients with a higher stroke risk are more likely to receive anticoagulation therapy with VKA but are underdosed compared with the global average in the GARFIELD-AF. CLINICAL TRIAL REGISTRATION-URL: http://www.clinicaltrials.gov. Unique identifier: NCT01090362

Fate and Effects of Salicylic Acid Compounds in Freshwater Systems.

The comparative fates and effects of salicylic acid (SA) and Na salicylate in algae (Scenedesmus subspicatus, Monoraphidium minutum), in Lemna minor, and in Daphnia magna were examined. Test methods were principally based on the OECD testing guidelines with modifications in the procedures. The influence of fulvic acid (FA) on bioconcentration and on toxic effects was studied. FA addition significantly reduced the bioavailability of SA in L. minor and the algae species. SA was more toxic to Lemnaceae, algae, and daphnids than to its Na salt. Bioconcentration factors in S. subspicatus, M. minutum, and L. minor were about 103 in 72&ndash;96 hr. The reproducibility of D. magna was reduced by 38% at a concentration of 20 mg SA/liter